More articles from psychopharmacology for the clinician

You have access
Long-acting injectable antipsychotics: choosing the right dose
David Carlone and Nicholas Delva

J Psychiatry Neurosci July 01, 2020 45 (4) 298; DOI: https://doi.org/10.1503/jpn.200015
You have access
Consensus statement on the use of clozapine during the COVID-19 pandemic
Dan Siskind, William G. Honer, Scott Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, John M. Kane, Deanna L. Kelly, Robert Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F. Schulte, David Taylor, Helene Verdoux, Amanda Wheeler and Oliver Freudenreich

J Psychiatry Neurosci May 01, 2020 45 (3) 222-223; DOI: https://doi.org/10.1503/jpn.200061
You have access
Mu-opioid antagonism in the treatment of cannabis use disorder
Oussama Kebir, Xavier Laqueille and Fayçal Mouaffak

J Psychiatry Neurosci March 01, 2020 45 (2) 143-144; DOI: https://doi.org/10.1503/jpn.190182
You have access
Kleptomania treated with naltrexone in a patient with intellectual disability
Faycal Mouaffak, Sonia Hamzaoui, Oussama Kebir and Xavier Laqueille

J Psychiatry Neurosci January 01, 2020 45 (1) 71-72; DOI: https://doi.org/10.1503/jpn.190064
You have access
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency
Nicolas Garel and Ridha Joober

J Psychiatry Neurosci November 01, 2019 44 (6) E31-E32; DOI: https://doi.org/10.1503/jpn.190081
You have access
Management of sexual adverse effects induced by atypical antipsychotic medication
Laura Downing, David D. Kim, Ric M. Procyshyn and Philip Tibbo

J Psychiatry Neurosci July 01, 2019 44 (4) 287-288; DOI: https://doi.org/10.1503/jpn.190053
You have access
N-Acetylcysteine augmentation in refractory obsessive–compulsive disorder
Sreenivasa Bhaskara

J Psychiatry Neurosci May 01, 2019 44 (3) 215-216; DOI: https://doi.org/10.1503/jpn.180179
You have access
Treating resistant depression with 2 forms of convulsive therapy: a clinical case study
Anastasios A. Daskalakis and Zafiris J. Daskalakis

J Psychiatry Neurosci March 01, 2019 44 (2) 143-144; DOI: https://doi.org/10.1503/jpn.180141
You have access
Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment
David D. Kim, Alasdair M. Barr, Randall F. White, William G. Honer and Ric M. Procyshyn

J Psychiatry Neurosci January 01, 2019 44 (1) 71-72; DOI: https://doi.org/10.1503/jpn.180087
You have access
Tic-related obsessive–compulsive disorder
Tamara Pringsheim and John Piacentini

J Psychiatry Neurosci November 01, 2018 43 (6) 431-432; DOI: https://doi.org/10.1503/jpn.180086

Main menu

User menu

Search

More articles from psychopharmacology for the clinician

Pages

Content

Authors & Reviewers

About